Ocular manifestation of rheumatoid arthritis-diff erent forms and frequency

Bosnian Journal of Basic Medical Sciences

Volumn 10, Issue 4, 2010, Pages 323-327

  Zlatanović, Gordana ^a   Veselinović, Dragan ^a   Cekić, Sonja ^b   Živković, Maja ^b   Dordević Jocić, Jasmina ^a   Zlatanović, Marko ^b  

^a UNIVERSITY OF NI   (Serbia)

^b Clinical Centre Nis   (Serbia)

Author keywords

Keratoconjunctivitis sicca; Retinal vasculitus; Rheumatoid arthritis; Scleritis

Indexed keywords

EID: 78649779215     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2010.2680     Document Type: Article

References (28)

1. Felson DT, Anderson JJ, Boers M. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-735
2. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann. Rheum Dis 2003;62722-727
3. Sahatçiu-Meka V, Rexhepi S, Manxhuka-Kërliu S, Rexhepi M. Ex-traaricular manifestation of seronegative and seropositive reuma-thoid arthritis Bosn. J Basic Med Sci 2010; 10 (1): 27-31
4. Lilleby V, Gran JT. Systemic rheumatoid arthritis: Tidsskr Nor Lae-geforen i997;ii7(29):4223-4225
5. Goronzy JJ, Weyand CM. Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ter 2009;11 (5)249
6. Cimmino MA, Salvarani C, Macchioni P., et al. Extra-articular manifestations in YZ Italian patients with rheumatoid arthritis. Rheumatollnt 200o;i9(6):2i3-2i7
7. Kanski JJ. The eye in systemic disease. Butterworts London 1986
8. Whitson WE, Krachmer JH. Adult rheumatoid arthritis. In: Gold DH, Weingeist TA. The eye in systemic disease, JB. Lippincott, Philadelphia, 1990; pp 127-208
9. Hakin KN, Ham J, Lightman SL. Use of orbital fl oor steroids in the management of patients with uniocular non-necrotizing scleritis. Brf Ophthalmol 1991:7 s(6):337-339
10. Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmol 20o8;115(10):1826-1832
11. Amett FC, Edworthy SM, Bloch DA. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-324.
12. Goto E, Matsumoto Y, Kamoi M, Endo K, Ishida R, Dogru M. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients. Am J Ophthalmol 2007; i44(i):8i-8s.
13. Ban CC, Davis H, Culberson WW. Rheumatoid scleritis. Ophthalmol 1981,88:1269-1273
14. Hori Y, Maeda N, Sakamoto M, Koh S, Inoue T, Tano Y Bacterio-logic profile of the conjunctiva in the patients with dry eye. Am] Ophthalmol 2008; 146(5)729-734.
15. Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS. In-fliximab therapy for the treatment of refractory ocular infl ammatory disease. Arch Ophthalmol 2007; i2s(7):895-900.
16. Foster C.S., Jabbur N.S. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmol I994;i0i{7):i28i-1286
17. Lin CP, Shih MH, Su CY. Scleritis. Surv Ophthalmol 2006; 5l(3):288-289;
18. Fong LP, Sainz de la Maza M, Rice BA, Kupferman AE, Foster CS. Immunopathology of scleritis. Ophthalmol 1991; 9 8 (4) 47 2-479.
19. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmol 1994;ioi(2):389-396.
20. Wakefield D, McCluskey P. Cyclosporin therapy for severe scleritis. Br J Ophthalmol 1989; 73(9)743-746.
21. Cazabon S, Over K, Butcher J. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye 2005;l9(2):222-224.
22. Murphy CC, Ayliff e WH, Booth A, Makanjuola D, Andrews PA, Jayne D. Tumor necrosis factor alpha blockade with infl iximab for refractory uveitis and scleritis. Ophthalmol 2004; ni(2):352-3s6.
23. Sobrin L., Kim EC, Christen W, Papadaki T, Letko E, Foster CS. Infliximab therapy for the treatment of refractory ocular infl ammatory disease. Arch Ophthalmol 2007; i2s(7):895-900.
24. Lamprecht P, Ai M, Gross WL. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab./lKK7?teMOTDB 2005;64(7):io87-io88.
25. Lim L, Suhler EB, Smith JR. Biologic therapies for inflammatory eye disease. Clin Exp Ophthalmol 20o6;34(4):36s-374.
26. Sobrin L, Christen W, Foster CS. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmol 20o8;iis{8):i4i6-i42i.
27. Papaliodis GN, Chu D, Foster CS. Treatment of ocular inflammatory disorders with daclizumab. Ophthalmol 2003:110(4)786-789.
28. Sokolović Š, Kasumagić S;Markić Durović M, Aganović Mušinović I. The impact of Rituximab therapy on the chromosomes of patients with rheumatoid arthritis. Bosn J Basic Med Sci 2010; 10 (2):121-124.